(Q63435894)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822059%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Antinociceptive activity of combination of morphine and NMDA receptor antagonists depends on the inter-injection interval (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822059%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

Irina V. Belozertseva

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822059%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Olga A Dravolina

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822059%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Anton Bespalov

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822059%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

4

Danysz W

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822059%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Neznanova ON

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822059%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822059%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822059%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

396

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822059%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822059%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

77-83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822059%20AND%20SRC:MED&resulttype=core&format=json

Effects of NMDA receptor channel blockers, dizocilpine and memantine, on the development of opiate analgesic tolerance induced by repeated morphine exposures or social defeats in mice.

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Short-acting NMDA receptor antagonist MRZ 2/576 produces prolonged suppression of morphine withdrawal in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene (SDZ EAA 494) in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Enhancement of morphine actions in morphine-naive and morphine-tolerant mice by LY 235959, a competitive antagonist of the NMDA receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Multiple effects of phorbol esters in the rat spinal dorsal horn.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Blockade of mu and kappa 1 opioid analgesic tolerance by NPC17742, a novel NMDA antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

1-Aminocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Acute tolerance associated with a single opiate administration: involvement of N-methyl-D-aspartate-dependent pain facilitatory systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Acute effects of morphine on the expression of mRNAs for NMDA receptor subunits in the rat hippocampus, hypothalamus and spinal cord.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Sex differences in the inhibitory effects of the NMDA antagonist, MK-801, on morphine and stress-induced analgesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Attenuation of nociceptive responses by ACEA-1021, a competitive NMDA receptor/glycine site antagonist, in the mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Blockade of morphine-induced analgesia and tolerance in mice by MK-801.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Delayed application of MK-801 attenuates development of morphine tolerance in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Effects of intrathecal NMDA and non-NMDA antagonists on acute thermal nociception and their interaction with morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Antagonistic effects of the selective, competitive N-methyl-D-aspartate (NMDA) receptor antagonist, NPC 12626, on kappa opiate-induced analgesia in male deer mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Behavioral classification of excitatory amino acid receptors in mouse spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Effects of acute morphine pretreatment on the rate-decreasing and antagonist activity of naloxone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

Acute tolerance in morphine analgesia: continuous infusion and single injection in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900184-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(00)00184-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822059%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference